Zhu Wei, Ann Chai Chu, Ma Jinxiang, İlker Gökce Mehmet, Gadzhiev Nariman, Kalathia Jaisukh, Jiang Kehua, Duan Xianzhong, Cao Jianwei, Wu Rongpei, Song Rijin, Bai Song, Li Xuedong, Liu Shusheng, Zeng Guohua
Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Department of Urology, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Eur Urol Open Sci. 2024 Nov 4;70:167-173. doi: 10.1016/j.euros.2024.10.014. eCollection 2024 Dec.
Guidelines recommend percutaneous nephrolithotomy (PCNL) for larger renal stones, but advances in flexible ureteroscopy (f-URS) with a tip-bendable suction ureteral access sheath (S-UAS) have prompted further investigation. Our multicenter, international, randomized controlled trial is investigating whether f-URS with S-UAS is noninferior to mini-PCNL (mPCNL) for renal stones of 2-3 cm. The primary objective is the immediate stone-free rate (SFR). Secondary outcomes include the 3-mo SFR, complication rates, surgical time, hospital stay, auxiliary procedures, and improvements in quality of life. A total of 720 patients from 12 urological centers will be randomized to either f-URS with S-UAS or PCNL. Statistical analyses will include intention-to-treat and per-protocol approaches, with specific methods for normally and non-normally distributed data. Subgroup analyses will focus on stone location and lithotripter types. The significance threshold will be set at < 0.05. The aim of this trial is to generate high-level evidence regarding the noninferiority of f-URS with S-UAS compared to mPCNL for medium-sized renal stones. The trial is registered on ClinicalTrials.gov as NCT06526390.
指南推荐对较大肾结石采用经皮肾镜取石术(PCNL),但可弯曲输尿管镜(f-URS)结合可弯曲尖端的输尿管吸引鞘(S-UAS)技术的进展促使了进一步研究。我们的多中心、国际随机对照试验正在研究对于2-3厘米的肾结石,f-URS结合S-UAS是否不劣于微创经皮肾镜取石术(mPCNL)。主要目标是即时无石率(SFR)。次要结局包括3个月时的无石率、并发症发生率、手术时间、住院时间、辅助操作以及生活质量改善情况。来自12个泌尿外科中心的720名患者将被随机分为f-URS结合S-UAS组或PCNL组。统计分析将包括意向性分析和符合方案分析方法,针对正态分布和非正态分布数据采用特定方法。亚组分析将聚焦于结石位置和碎石设备类型。显著性阈值设定为<0.05。本试验的目的是产生关于f-URS结合S-UAS与mPCNL治疗中等大小肾结石非劣效性的高级别证据。该试验已在ClinicalTrials.gov上注册,注册号为NCT06526390。